showed a trendp = 0.055
3.3 mo, p = 0.02) and showed a trend for longer mOS (20.9 vs. 12.5 mo, p = 0.055) compared with those not closely matched.
3.3 mo, p = 0.02) and showed a trend for longer mOS (20.9 vs. 12.5 mo, p = 0.055) compared with those not closely matched.
Patients whose regimens more closely matched assay results had numerically superior median OS compared to those not closely matched, though this did not reach statistical significance ( Figure 1 B).
The current study demonstrates a clear trend toward benefit, with regard to both time on line of therapy and median OS, based on the number of drugs administered that were predicted by the assay to be effective.